Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 6/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 5/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acesulfame SCHEMBL17350389 | 1.00 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL7594675 | 0.98 | CA9 (1.00) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL3551 | 0.98 | CA9 (1.00) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL17350249 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL38654964 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL17766790 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL7568032 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL38656077 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL328789 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 | |
| Acesulfame SCHEMBL3126570 | 0.96 | CA9 (0.96) | CA9KMT2ACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12137710-B2 | Food composition, for alleviating diabetes, comprising Schisandra chinensis fruit juice and bean juice and preparation method thereof | KOREA FOOD RESEARCH INSTITUTE (KR) | 2024-11-12 | — | — | US | claimed |
| US-20220117275-A1 | FOOD COMPOSITION, FOR ALLEVIATING DIABETES, COMPRISING SCHISANDRA CHINENSIS FRUIT JUICE AND BEAN JUICE AND PREPARATION METHOD THEREOF | KOREA FOOD RESEARCH INSTITUTE (KR) | 2022-04-21 | — | — | US | claimed |
| EP-3912482-A1 | FOOD COMPOSITION, FOR ALLEVIATING DIABETES, COMPRISING OMIJA AND BEAN JUICE, AND PREPARATION METHOD THEREOF | Korea Food Research Institute (KR) | 2021-11-24 | — | — | EP | claimed |
| WO-2020149506-A1 | FOOD COMPOSITION, FOR ALLEVIATING DIABETES, COMPRISING OMIJA AND BEAN JUICE, AND PREPARATION METHOD THEREOF | 한국식품연구원 | 2020-07-23 | — | — | WO | claimed |
| US-10272131-B2 | Linaclotide stable composition | SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) | 2019-04-30 | — | — | US | claimed |
| US-20170232058-A1 | LINACLOTIDE STABLE COMPOSITION | SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) | 2017-08-17 | — | — | US | claimed |
| CN-102285943-A | Production method and application of acesulfame calcium | — | 2011-12-21 | — | — | CN | claimed |
| US-12137710-B2 | Food composition, for alleviating diabetes, comprising Schisandra chinensis fruit juice and bean juice and preparation method thereof | KOREA FOOD RESEARCH INSTITUTE (KR) | 2024-11-12 | — | — | US | disclosed |
| US-20220117275-A1 | FOOD COMPOSITION, FOR ALLEVIATING DIABETES, COMPRISING SCHISANDRA CHINENSIS FRUIT JUICE AND BEAN JUICE AND PREPARATION METHOD THEREOF | KOREA FOOD RESEARCH INSTITUTE (KR) | 2022-04-21 | — | — | US | disclosed |
| CN-113747948-A | Reduction of tooth staining from cationic antimicrobial agents | 宝洁公司 | 2021-12-03 | — | — | CN | disclosed |
| EP-3912482-A1 | FOOD COMPOSITION, FOR ALLEVIATING DIABETES, COMPRISING OMIJA AND BEAN JUICE, AND PREPARATION METHOD THEREOF | Korea Food Research Institute (KR) | 2021-11-24 | — | — | EP | disclosed |
| CN-112585690-A | System and method for producing individualized individual unit doses containing a pharmaceutically active substance | 阿奎斯蒂弗医疗股份有限公司 | 2021-03-30 | — | — | CN | disclosed |
| WO-2020149506-A1 | FOOD COMPOSITION, FOR ALLEVIATING DIABETES, COMPRISING OMIJA AND BEAN JUICE, AND PREPARATION METHOD THEREOF | 한국식품연구원 | 2020-07-23 | — | — | WO | disclosed |
| EP-3180016-A1 | LINACLOTIDE STABLE COMPOSITION | Sun Pharmaceutical Industries Ltd (IN) | 2017-06-21 | — | — | EP | disclosed |
| WO-2016024291-A1 | LINACLOTIDE STABLE COMPOSITION | SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) | 2016-02-18 | — | — | WO | disclosed |
| WO-2012007170-A1 | USE OF ACESULFAME K AS A FLAVOUR MODULATOR | NUTRINOVA NUTRITION SPECIALITIES AND FOOD INGREDIENTS GMBH (DE) | 2012-01-19 | — | — | WO | disclosed |
| EP-2407146-A1 | Use of acesulfame K as a flavour modulator | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2012-01-18 | — | — | EP | disclosed |
| CN-102285943-A | Production method and application of acesulfame calcium | — | 2011-12-21 | — | — | CN | disclosed |
| CN-102285943-A | Production method and application of acesulfame calcium | — | 2011-12-21 | — | — | CN | disclosed |
| CN-102285943-A | Production method and application of acesulfame calcium | — | 2011-12-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170232058-A1 | LINACLOTIDE STABLE COMPOSITION | LPXN, LSS, ACE | CA9 3270/4885KMT2A 1939/4885CA12 2384/4885 |
| US-10272131-B2 | Linaclotide stable composition | LPXN, LSS, ACE | CA9 3270/4885KMT2A 1939/4885CA12 2384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.